Common use of Event Amount Clause in Contracts

Event Amount. If Net Sales of Approved Alemtuzumab MS in the Territory reach US $[**] in any contiguous twelve (12) month period between [**] and [**] [**]% of Net Sales of Approved Alemtuzumab MS in the Territory in the first such twelve (12) month period If Net Sales of Approved Alemtuzumab MS in the Territory reach US $[**] in any contiguous twelve (12) month period between [**] and [**] [**]% of Net Sales of Approved Alemtuzumab MS in the Territory in the first such twelve (12) month period If Net Sales of Approved Alemtuzumab MS in the Territory reach US $[**] in any contiguous twelve (12) month period from [**] and [**] [**]% of Net Sales of Approved Alemtuzumab MS in the Territory in the first such twelve (12) month period If Net Sales of Approved Alemtuzumab MS in the Territory reach US $[**] in any contiguous twelve (12) month period from [**] and [**] [**]% of Net Sales of Approved Alemtuzumab MS in the Territory in the first such twelve (12) month period If any of the four (4) milestones in Section 4.2.2 is met in [**] during the [**] time period specified for such milestone, then the [**] where such milestone is reached shall be used to determine Net Sales with regard to the applicable Alemtuzumab MS Milestone Payment. Each of the four (4) Alemtuzumab MS Milestone Payments under this Section 4.2.2 will only be payable the first time such milestone is reached.

Event Amount. If Net Sales of Approved Alemtuzumab MS in the Territory reach US $[**] in any contiguous twelve (12) month period between [**] and [**] [**]% of Net Sales of Approved Alemtuzumab MS in the Territory in the first such twelve (12) month period If Net Sales of Approved Alemtuzumab MS in the Territory reach US $[**] in any contiguous twelve (12) month period between [**] and [**] [**]% of Net Sales of Approved Alemtuzumab MS in the Territory in the first such twelve (12) month period If Net Sales of Approved Alemtuzumab MS in the Territory reach US $[**] in any contiguous twelve (12) month period from [**] and [**] [**]% of Net Sales of Approved Alemtuzumab MS in the Territory in the first such twelve (12) month period If Net Sales of Approved Alemtuzumab MS in the Territory reach US $[**] in any contiguous twelve (12) month period from [**] ]and [**] [**]% of Net Sales of Approved Alemtuzumab MS in the Territory in the first such twelve (12) month period If any of the four (4) milestones in Section 4.2.2 is met in [**] during the [**] time period specified for such milestone, then the [**] where such milestone is reached shall be used to determine Net Sales with regard to the applicable Alemtuzumab MS Milestone Payment. Each of the four (4) Alemtuzumab MS Milestone Payments under this Section 4.2.2 will only be payable the first time such milestone is reached.